effectiveness of subcotaneous injection of piroxicam compared with oral use of piroxicam in pain improvement in patients with knee osteoarthritis.

Not Applicable

Recruiting

• Conditions: arthrosis.; primary gonarthrosis,bilateral; other primary gonarthrosis; M17.0; M17.

• Registration Number: IRCT2017052434113N1
• Lead Sponsor: vice chancellor for research of shiraz university of medical science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

inclusion criteria:40-70y/o patients with mild to moderate osteoarthritis with clinical symptoms at least recent 1month;
exclusion criteria:disease suchvas:DM,collagen vascular and rheumatism,gout,neuropathy,radiculopathy,nerve injury,brucella,BMI>42,trauma ,bleeding tendency,significant hepatic,renal and cardiopulmonaryproblems,knee arthroplasty,allergy to piroxicam,knee injection in recent 3month,pregnancy,cancer,cognitive disorders.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain improvement. Timepoint: befor intervention,2and4weeks after intervention. Method of measurement: VAS,WOMAC,AXFORD questionnaires.

Secondary Outcome Measures

Name	Time	Method
Improvement in function. Timepoint: before intervention,2 and 4 weeks after intervention. Method of measurement: VAS,WOMAC,AXFORD questionnaires.